Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ertugliflozin in T2DM with Stage 3 CKD
NCT01986855Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Dec 2013
- Primary completion
- Sep 2016
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ertugliflozin in type 2 diabetes mellitus (T2DM), sponsored by Merck & Co.. Started Dec 2013; status: completed.
02
Drugs
ertugliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01986855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01986855.